Nasal Spray Development and CDMO Expertise
Basic Pharma is your trusted partner in nasal spray development, offering integrated CDMO solutions from early formulation to GMP commercial manufacturing. We support both generic and innovative nasal drug products with proven scientific expertise, modern infrastructure, and full regulatory alignment.
End-to-End Capabilities in Nasal Spray Development
Our development programs cover the complete lifecycle of a nasal spray product. This includes:
Formulation & Analytical Development
We provide formulation development for solutions and suspensions, packaging compatibility studies, and analytical method development. Our analytical team establishes and validates robust non-pharmacopeial methods (e.g. assay and impurities), tailored to critical quality attributes of nasal spray drug products.
Stability Testing & In Vitro Studies
Stability studies are conducted in-house in newly installed climate chambers configured for Climatic Zones II, IVa, and IVb. In vitro bioequivalence studies support generic nasal spray development and help justify regulatory requirements based on scientific evidence.
For more information on our analytical capabilities, visit our Laboratory Division.
Nasal Spray Manufacturing Under GMP
Basic Pharma offers GMP nasal spray manufacturing from pilot scale to commercial batches. Our facilities supports non-sterile production, including precise nasal spray filling, packaging, and full technical transfer activities. These manufacturing capabilities ensure consistent product
Therapeutic Areas and API Expertise
We have extensive experience with widely used nasal spray APIs, including Xylometazoline, Mometasone Furoate, Fluticasone Propionate, Fluticasone Furoate, and Azelastine-based combinations for seasonal allergic rhinitis. Our expertise reduces development risk and accelerates timelines for both generic and innovative therapies.
Partner With a Leading Nasal Spray CDMO
As a specialized nasal spray CDMO, we support clients from concept to commercial production. Our scientific knowledge, modern infrastructure, and integrated development model enable efficient, compliant, and successful nasal spray product launches.